Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-operative vs Post-operative FEC in Operable Breast Cancer
NCT00544505Phase 3Unknown
- Sponsor
- King Faisal Specialist Hospital and Research Centre
- Start
- Sep 2007
- Primary completion
- Sep 2012
- Modality
- DNA Intercalators/Alkylators
01
Overview
A Phase 3 trial of fluorouracil, epirubicin, cyclophosphamide in breast cancer, sponsored by King Faisal Specialist Hospital and Research Centre. Status: unknown.
02
Drugs
fluorouracilepirubicincyclophosphamide
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00544505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00544505.